NQO1 and hepatocellular carcinoma: Therefore, the mRNA expression levels of the CSC markers CD133 and EpCAM, and NRF2 and its target genes NQO1, HO-1, GCLC and GCLM alone and in combination were analyzed to evaluate their association with the prognosis of TAE/TACE-treated HCC patients.